Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Phase 2a trial of GSBR-1290 (45mg and 90mg) in 54 T2DM patients over 12 weeks observed significant reduction in HbA1c (45 mg: -1.01%, p=0.008
L., Haupt, A., Milicevic, Z., & Coskun, T
Following any MHRA marketing authorisation, NICE (the National Institute for Health and Care Excellence) would be expected to conduct a technology appraisal to determine whether retatrutide represents a cost-effective use of NHS resources and to establish guidance on appropriate patient populations
Provider-supervised titration accounts for individual tolerance, renal function, cardiovascular history, and any medications you take
US$ 29.00
US$ 25.83
US$ 20.06
US$ 28.20
US$ 26.67
US$ 21.90
US$ 23.80
US$ 22.02
